Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OX9W
|
|||
| Former ID |
DCL000847
|
|||
| Drug Name |
Inolimomab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Heart transplant rejection [ICD-11: NE84; ICD-9: 996] | Phase 3 | [1] | |
| Company |
EUSA Pharma
|
|||
| SuperDrug ATC ID |
A11GA01
|
|||
| SuperDrug CAS ID |
cas=000050817
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21. | |||
| REF 2 | Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease.Biol Blood Marrow Transplant.2006 Nov;12(11):1135-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.